BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19842433)

  • 1. Structure and function of HIV-1 CRF01_AE envelope proteins from blood and genital fluid isolates.
    Horthongkham N; Athipanyasilp N; Siritantikorn S; Kantakamalakul W; Srisurapanon S; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):480-93. PubMed ID: 19842433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1.
    Prohászka Z; Hidvégi T; Ujhelyi E; Stoiber H; Dierich MP; Süsal C; Füst G
    Immunology; 1995 Jun; 85(2):184-9. PubMed ID: 7642209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single point mutation in HIV-1 V3 loop alters the immunogenic properties of rgp120.
    Lee SK; Pestano GA; Riley J; Hasan AS; Pezzano M; Samms M; Park KJ; Guyden J; Boto WM
    Arch Virol; 2000; 145(10):2087-103. PubMed ID: 11087093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.
    Connor RI; Korber BT; Graham BS; Hahn BH; Ho DD; Walker BD; Neumann AU; Vermund SH; Mestecky J; Jackson S; Fenamore E; Cao Y; Gao F; Kalams S; Kunstman KJ; McDonald D; McWilliams N; Trkola A; Moore JP; Wolinsky SM
    J Virol; 1998 Feb; 72(2):1552-76. PubMed ID: 9445059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects?
    Klasse PJ; Moore JP
    Virology; 2004 May; 323(1):1-8. PubMed ID: 15165814
    [No Abstract]   [Full Text] [Related]  

  • 8. Sendai virus-based production of HIV type 1 subtype B and subtype E envelope glycoprotein 120 antigens and their use for highly sensitive detection of subtype-specific serum antibodies.
    Toriyoshi H; Shioda T; Sato H; Sakaguchi M; Eda Y; Tokiyoshi S; Kato K; Nohtomi K; Kusagawa S; Taniguchi K; Shiino T; Kato A; Foongladda S; Linkanonsakul S; Oka SI; Iwamoto A; Wasi C; Nagai Y; Takebe Y
    AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1109-20. PubMed ID: 10461831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
    Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
    AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
    Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines.
    Lachman LB; Shih LC; Rao XM; Hu X; Bucana CD; Ullrich SE; Cleland JL
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):921-32. PubMed ID: 7492439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.
    Zhang C; Xu S; Wei J; Guo H
    Int J Infect Dis; 2009 Sep; 13(5):e212-6. PubMed ID: 19217335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive radioimmunoprecipitation assay for the detection and quantitation of antibodies to the envelope glycoprotein gp120 of the human immunodeficiency virus (HIV-1).
    Lucas C; Peterson ML; Bennett GL; Frie SW; Berman PW; Chen AB
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):357-70. PubMed ID: 2340201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant gp120, antibodies to the V3 region of gp120, and neural progenitor cells.
    Klasse PJ; Barnes KC; Moore JP
    J Infect Dis; 2005 Mar; 191(5):815-6; author reply 816-8. PubMed ID: 15688301
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells.
    Du SX; Xu L; Viswanathan S; Whalen RG
    Protein Expr Purif; 2008 Jun; 59(2):223-31. PubMed ID: 18406166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the variation of 32 HIV-1 V3 loop from infected Chinese blood/plasma donors].
    Dai L; Lu JF; Huang XJ; Shi Y; Chen DX; Wu H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):27-9. PubMed ID: 18414693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies.
    Jones DH; McBride BW; Roff MA; Farrar GH
    Vaccine; 1995 Aug; 13(11):991-9. PubMed ID: 8525694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.
    Center RJ; Wheatley AK; Campbell SM; Gaeguta AJ; Peut V; Alcantara S; Siebentritt C; Kent SJ; Purcell DF
    Vaccine; 2009 Nov; 27(47):6605-12. PubMed ID: 19712773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.
    Santos-Costa Q; Parreira R; Moniz-Pereira J; Azevedo-Pereira JM
    J Med Virol; 2009 Nov; 81(11):1869-81. PubMed ID: 19774680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.
    Leal E; Silva WP; Sucupira MC; Janini LM; Diaz RS
    Virology; 2008 Nov; 381(2):222-9. PubMed ID: 18814897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.